Metastatic melanoma: ChemotherapyEmilio Bajetta, David Khayat, Sophie Taillibert et al.|Seminars in Oncology|2002Cited by 165
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-α2b in metastatic melanomaE. Bajetta, N. Cascinelli, Michele Del Vecchio et al.|Annals of Oncology|2006Cited by 114
Renal Cancer Treatment: A Review of the LiteratureLuca Gattinoni, Emilio Bajetta, Massimiliano Alù et al.|Tumori Journal|2003Cited by 17
837 Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous (SC) interleukin-2 (IL-2) and interferon-alpha-2b (IFN) in metastatic melanomaEmilio Bajetta, Maria Grazia Bernengo, M.R. Sertoli et al.|European Journal of Cancer Supplements|2003Cited by 5